Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
24.04
+0.34 (1.43%)
At close: May 29, 2025, 4:00 PM
24.47
+0.43 (1.79%)
After-hours: May 29, 2025, 5:18 PM EDT

Janux Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
1,4233,087495547821-
Upgrade
Market Cap Growth
-17.94%523.34%-9.51%-33.35%--
Upgrade
Enterprise Value
4312,452170233434-
Upgrade
Last Close Price
24.0453.5410.7313.1719.73-
Upgrade
PS Ratio
146.61291.5461.2763.54225.73-
Upgrade
PB Ratio
1.403.021.441.712.24-
Upgrade
P/TBV Ratio
1.413.021.441.712.24-
Upgrade
EV/Sales Ratio
46.17231.6021.0827.00119.25-
Upgrade
Debt / Equity Ratio
0.020.020.070.080.00-
Upgrade
Asset Turnover
0.010.020.020.020.02-
Upgrade
Quick Ratio
58.2659.0326.5619.8529.324.97
Upgrade
Current Ratio
58.4759.2126.8020.1429.465.05
Upgrade
Return on Equity (ROE)
-9.32%-10.09%-17.53%-18.36%-17.50%-446.61%
Upgrade
Return on Assets (ROA)
-8.16%-8.57%-12.25%-11.27%-10.39%-35.83%
Upgrade
Return on Capital (ROIC)
-8.28%-8.73%-12.76%-11.77%-11.02%-86.02%
Upgrade
Earnings Yield
-5.46%-2.23%-11.77%-11.52%-3.98%-
Upgrade
FCF Yield
-3.27%-1.43%-10.59%-9.02%-2.25%-
Upgrade
Buyback Yield / Dilution
-24.21%-22.12%-6.14%-76.24%-2471.20%-36.71%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q